Sitting alone can provoke CBF reductions in severe ME/CFS

A 2020 paper by van Campen and Rowe in Healthcare extended an important methodological principle to its most consequential application: in severe ME/CFS, even sitting upright is enough orthostatic stress to produce large, measurable cerebral blood flow reductions — reductions that standard heart rate and blood pressure monitoring will miss entirely. The paper does not just document a physiological finding. It identifies a systematic failure of clinical evaluation to detect it, and explains why patients with severe ME/CFS are repeatedly discharged from assessments as "normal" when their cerebral blood flow data have never been measured.

The Study Design: Addressing the Severe Patient Problem

Standard orthostatic research in ME/CFS typically uses 70-degree head-up tilt for 30 minutes or a 10-minute standing test. These protocols are appropriate for patients with moderate impairment who can tolerate extended upright posture. For patients with severe ME/CFS — those who are bedbound or chair-bound, who cannot stand for extended periods, and for whom any prolonged upright posture produces significant symptom exacerbation — these protocols are physiologically inaccessible. The standard test excludes the most severely affected population from the very evaluation that might detect their physiology.

Van Campen and Rowe recruited severe ME/CFS patients who could tolerate sitting but not standing, and applied a sitting protocol. Patients moved from lying flat to seated upright for ten minutes while cerebral blood flow velocity was measured continuously using transcranial Doppler ultrasonography. Heart rate and blood pressure were also monitored throughout. Controls underwent the same protocol.

The sitting posture produces less gravitational pooling than standing, but it still creates a measurable orthostatic challenge. The question was whether that reduced challenge was sufficient to produce detectable cerebral blood flow changes in this population. The answer was unambiguous.

The Finding: 24.5% CBF Reduction From Sitting Alone

In the severe ME/CFS group, moving from lying to sitting produced a mean cerebral blood flow velocity reduction of approximately 24.5% compared to baseline. This is a large effect. In healthy adults and milder ME/CFS patients, the same positional change produced negligible cerebral blood flow changes — the autoregulatory and vasoconstrictor responses that maintain cerebral perfusion through positional changes were doing their job.

In the severe patients, those regulatory mechanisms were failing to compensate for even the modest gravitational challenge of sitting upright. The brain was receiving substantially less blood flow in the seated position than in the supine position, by a margin that is physiologically significant and symptomatically consequential.

The heart rate and blood pressure findings: neither changed meaningfully in either group. The standard clinical metrics that orthostatic evaluations rely on were flat. If the attending clinician had observed only the heart rate and blood pressure — which is what a standard assessment does — they would have concluded that nothing happened when these patients sat up. No tachycardia. No hypotension. No objective findings. The cerebral blood flow data, which were not part of the standard protocol, told a completely different story.

What "Normal Vitals" Actually Means in Severe ME/CFS

This finding has a direct implication for how "normal" evaluations should be interpreted. A severe ME/CFS patient who undergoes a standard clinical assessment — resting vital signs, brief stand test with heart rate and blood pressure monitoring — and is found to have "normal" results has not been found to have normal physiology. They have been found to have normal heart rate and blood pressure. Their cerebral blood flow was not assessed.

The research establishing that normal vitals do not predict normal brain blood flow applies directly here. But the sitting paper adds a lower threshold: these patients do not even need to stand to show substantial cerebral hypoperfusion. The orthostatic stress of sitting is sufficient. Activities that seem trivial from a clinical standpoint — sitting upright to speak with a clinician, sitting at a table to eat, sitting in a car for a short journey — may be repeatedly producing cerebral hypoperfusion episodes in severe ME/CFS patients. Each of those episodes produces the symptom cluster that follows from inadequate brain perfusion: cognitive impairment, fatigue, headache, post-exertional worsening.

The Post-Exertional Malaise Connection

Post-exertional malaise — the hallmark of ME/CFS where even mild activity produces symptoms that worsen over the following 12–48 hours — is one of the most poorly understood features of the condition from a mechanistic standpoint. The sitting study offers a partial explanation for why activities that appear minor from the outside can produce significant crashes: even sitting produces cerebral hypoperfusion in severe patients, and repeated episodes of cerebral hypoperfusion over the course of a day — each one individually modest and unmeasurable by standard metrics — may accumulate to produce the worsening that characterizes post-exertional malaise.

This does not mean sitting is dangerous and should be avoided. It means that understanding the orthostatic threshold in severe ME/CFS — how much positional change, for how long, produces meaningful cerebral blood flow reduction — is clinically important information that determines what activities are sustainable for a given patient. That threshold is currently not being measured in standard care.

What You Now Know That the Standard Evaluation Does Not Provide

If you have severe ME/CFS and have been told your evaluations are normal because your heart rate and blood pressure did not change significantly on a standing test or even a sitting assessment: the van Campen and Rowe data establish that this evaluation was not testing what is causing your symptoms. Cerebral blood flow reduction of nearly 25% from sitting alone, without any change in heart rate or blood pressure, is the physiological pattern this population shows when directly measured with transcranial Doppler. Standard assessment does not use transcranial Doppler. It uses the wrong tools, and it concludes from those tools that nothing is wrong.

The right test for severe ME/CFS may not be a standing test at all. It may be a seated protocol with cerebral blood flow velocity monitoring. The protocol exists. It has been applied. The findings are not consistent with "normal." They are consistent with a condition whose cardinal physiological mechanism — impaired cerebral perfusion in response to modest gravitational challenge — has simply not been measured in the clinical settings where these patients have been evaluated.